Tower Research Capital (TRC)’s Akso Health Group AHG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,435
Closed -$7K 6056
2021
Q4
$7K Buy
+4,435
New +$16.4K ﹤0.01% 4885
2019
Q4
Sell
-3,453
Closed -$16K 3459
2019
Q3
$16K Buy
3,453
+1,541
+81% +$9.66K ﹤0.01% 2600
2019
Q2
$14K Buy
1,912
+587
+44% +$4.9K ﹤0.01% 2367
2019
Q1
$13K Buy
+1,325
New +$11.5K ﹤0.01% 2513
2018
Q4
Sell
-14
Closed 3786
2018
Q3
$0 Buy
+14
New +$363 ﹤0.01% 3711
2018
Q2
Sell
-26
Closed -$1K 3595
2018
Q1
$1K Buy
+26
New +$861 ﹤0.01% 3041

Other funds holding AHG

Tower Research Capital (TRC)'s AHG Position: Q1 2022 in Review

Tower Research Capital (TRC) sold out of Akso Health Group (AHG) in Q1 2022, closing a stake of 4,435 shares — an estimated $7K sold.

Tower Research Capital (TRC) first reported a position in AHG in Q1 2018 and held it in 6 quarters. The position peaked at $16K in Q3 2019. 7 funds tracked by Wall St. Rank hold AHG as of Q1 2022.

  • Tower Research Capital (TRC) reported no remaining Akso Health Group position as of Q1 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 4,435 Akso Health Group shares in Q1 2022, an estimated $7K.
  • Tower Research Capital (TRC) first reported a position in Akso Health Group in Q1 2018 and held it in 6 quarters.
  • Tower Research Capital (TRC)'s Akso Health Group position peaked at $16K in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Akso Health Group as of Q1 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.